Stephen A Spencer, Florence Malowa, David McCarty, Elizabeth Joekes, Jacob Phulusa, Beatrice Chinoko, Sylvester Kaimba, Lucy Keyala, Peter Mandala, Mercy Mkandawire, Albert Mukatipa, Mulinda Nyirenda, Hendry R Sawe, Sarah A White, Marc Y R Henrion, Daniel X Augustine, David Oxborough, Eve Worrall, Felix Limbani, Paul Dark, Jamie Rylance, Stephen B Gordon, Ben Morton
{"title":"急性呼吸困难是马拉维住院的一个原因:一项评估原因和结果的前瞻性、以患者为中心的研究","authors":"Stephen A Spencer, Florence Malowa, David McCarty, Elizabeth Joekes, Jacob Phulusa, Beatrice Chinoko, Sylvester Kaimba, Lucy Keyala, Peter Mandala, Mercy Mkandawire, Albert Mukatipa, Mulinda Nyirenda, Hendry R Sawe, Sarah A White, Marc Y R Henrion, Daniel X Augustine, David Oxborough, Eve Worrall, Felix Limbani, Paul Dark, Jamie Rylance, Stephen B Gordon, Ben Morton","doi":"10.1136/thorax-2025-223623","DOIUrl":null,"url":null,"abstract":"Introduction Breathlessness is a common cause of hospital admission globally and is associated with high mortality, particularly in low-income countries. In sub-Saharan Africa, there is a paucity of data on breathlessness, with existing data focused on individual diseases. There is a need for patient-centred approaches to understand interactions between multiple conditions to address population needs and inform health system responses. This multicentre prospective study in Malawi aimed to characterise the aetiologies, outcomes and biomarker accuracy for breathless patients. Methods Adults (aged ≥18 years) admitted to medical wards were consecutively recruited within 24 hours of hospital presentation and followed up for 1 year. Participants with breathlessness (defined as a composite of patient-reported shortness of breath; tachypnoea (respiratory rate ≥25/min); hypoxaemia (SpO2 <94%) or treatment with oxygen) were systematically screened against internationally accepted diagnostic criteria. We estimated disease prevalence, survival, health-related quality of life and functional status. We also evaluated diagnostic accuracy of natriuretic peptides for heart failure, and procalcitonin (PCT) and C reactive peptide (CRP) for pneumonia. Results Of 751 participants, 44% (n=334) had breathlessness, and 316 underwent enhanced diagnostic screening. One-year mortality was higher in breathless patients (51% (157/307)) than those without (26% (100/385)); adjusted HR 1.8 (95% CI 1.4 to 2.3). We identified high prevalence and mortality of heart failure (35% (112/316) prevalence; 69% (75/109) 1-year mortality), anaemia (40% (126/316); 57% (70/122)), pneumonia (41% (131/316); 53% (68/129)) and tuberculosis (29% (91/316); 47% (41/87)). Most participants (63% (199/316)) had multiple conditions. Diagnostic accuracy (area under the curve) for heart failure was 0.89 (brain natriuretic peptide) and 0.88 (N-terminal pro-B-type natriuretic peptide); for pneumonia, CRP was 0.77 and PCT was 0.69. Discussion Breathlessness-related hospital admissions in Malawi are common, multifactorial and associated with poor survival. This study demonstrates that co-existing conditions are common, highlighting the limitation of single-disease-focused health system responses. Integrated care pathways with context-sensitive diagnostic and treatment approaches are urgently needed to improve survival. Data are available on reasonable request. An anonymised study dataset can be shared within Malawi in line with local data sharing policies. Requests for data sharing outside Malawi can be presented to the MultiLink management committee via our programme manager, Amy Smith (Amy.Smith{at}lstmed.ac.uk).","PeriodicalId":23284,"journal":{"name":"Thorax","volume":"42 1","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomes\",\"authors\":\"Stephen A Spencer, Florence Malowa, David McCarty, Elizabeth Joekes, Jacob Phulusa, Beatrice Chinoko, Sylvester Kaimba, Lucy Keyala, Peter Mandala, Mercy Mkandawire, Albert Mukatipa, Mulinda Nyirenda, Hendry R Sawe, Sarah A White, Marc Y R Henrion, Daniel X Augustine, David Oxborough, Eve Worrall, Felix Limbani, Paul Dark, Jamie Rylance, Stephen B Gordon, Ben Morton\",\"doi\":\"10.1136/thorax-2025-223623\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction Breathlessness is a common cause of hospital admission globally and is associated with high mortality, particularly in low-income countries. In sub-Saharan Africa, there is a paucity of data on breathlessness, with existing data focused on individual diseases. There is a need for patient-centred approaches to understand interactions between multiple conditions to address population needs and inform health system responses. This multicentre prospective study in Malawi aimed to characterise the aetiologies, outcomes and biomarker accuracy for breathless patients. Methods Adults (aged ≥18 years) admitted to medical wards were consecutively recruited within 24 hours of hospital presentation and followed up for 1 year. Participants with breathlessness (defined as a composite of patient-reported shortness of breath; tachypnoea (respiratory rate ≥25/min); hypoxaemia (SpO2 <94%) or treatment with oxygen) were systematically screened against internationally accepted diagnostic criteria. We estimated disease prevalence, survival, health-related quality of life and functional status. We also evaluated diagnostic accuracy of natriuretic peptides for heart failure, and procalcitonin (PCT) and C reactive peptide (CRP) for pneumonia. Results Of 751 participants, 44% (n=334) had breathlessness, and 316 underwent enhanced diagnostic screening. One-year mortality was higher in breathless patients (51% (157/307)) than those without (26% (100/385)); adjusted HR 1.8 (95% CI 1.4 to 2.3). We identified high prevalence and mortality of heart failure (35% (112/316) prevalence; 69% (75/109) 1-year mortality), anaemia (40% (126/316); 57% (70/122)), pneumonia (41% (131/316); 53% (68/129)) and tuberculosis (29% (91/316); 47% (41/87)). Most participants (63% (199/316)) had multiple conditions. Diagnostic accuracy (area under the curve) for heart failure was 0.89 (brain natriuretic peptide) and 0.88 (N-terminal pro-B-type natriuretic peptide); for pneumonia, CRP was 0.77 and PCT was 0.69. Discussion Breathlessness-related hospital admissions in Malawi are common, multifactorial and associated with poor survival. This study demonstrates that co-existing conditions are common, highlighting the limitation of single-disease-focused health system responses. Integrated care pathways with context-sensitive diagnostic and treatment approaches are urgently needed to improve survival. Data are available on reasonable request. An anonymised study dataset can be shared within Malawi in line with local data sharing policies. Requests for data sharing outside Malawi can be presented to the MultiLink management committee via our programme manager, Amy Smith (Amy.Smith{at}lstmed.ac.uk).\",\"PeriodicalId\":23284,\"journal\":{\"name\":\"Thorax\",\"volume\":\"42 1\",\"pages\":\"\"},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thorax\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/thorax-2025-223623\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thorax","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/thorax-2025-223623","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
呼吸困难是全球住院的常见原因,与高死亡率有关,特别是在低收入国家。在撒哈拉以南非洲,缺乏关于呼吸困难的数据,现有数据主要集中在个别疾病上。有必要采取以患者为中心的方法,了解多种疾病之间的相互作用,以满足人群需求并为卫生系统应对提供信息。马拉维的这项多中心前瞻性研究旨在描述呼吸困难患者的病因、结局和生物标志物准确性。方法选取就诊24小时内住院的成人(年龄≥18岁),随访1年。呼吸困难(定义为患者报告的呼吸短促、呼吸急促(呼吸频率≥25/min);根据国际公认的诊断标准对低氧血症(SpO2 <94%)或氧治疗进行系统筛选。我们评估了疾病患病率、生存率、健康相关生活质量和功能状态。我们还评估了利钠肽对心力衰竭的诊断准确性,以及降钙素原(PCT)和C反应肽(CRP)对肺炎的诊断准确性。结果在751名参与者中,44% (n=334)患有呼吸困难,316人接受了增强的诊断筛查。呼吸困难患者的1年死亡率(51%(157/307))高于无呼吸困难患者(26% (100/385));调整后危险度为1.8 (95% CI 1.4 ~ 2.3)。我们确定了心力衰竭的高患病率和死亡率(35% (112/316));1年死亡率69%(75/109),贫血(40% (126/316);57%(70/122)),肺炎(41% (131/316);53%(68/129))和肺结核(29% (91/316);47%(41/87))。大多数参与者(63%(199/316))患有多种疾病。心衰的诊断准确率(曲线下面积)分别为0.89(脑钠肽)和0.88 (n端前b型钠肽);肺炎CRP为0.77,PCT为0.69。在马拉维,与呼吸困难相关的住院是常见的,多因素的,与生存率低有关。该研究表明,共存条件是常见的,突出了以单一疾病为重点的卫生系统反应的局限性。迫切需要综合护理途径与环境敏感的诊断和治疗方法,以提高生存率。如有合理要求,可提供资料。一个匿名的研究数据集可以根据当地的数据共享政策在马拉维境内共享。马拉维以外的数据共享请求可以通过我们的项目经理Amy Smith (Amy.Smith{at}lstmed.ac.uk)提交给MultiLink管理委员会。
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomes
Introduction Breathlessness is a common cause of hospital admission globally and is associated with high mortality, particularly in low-income countries. In sub-Saharan Africa, there is a paucity of data on breathlessness, with existing data focused on individual diseases. There is a need for patient-centred approaches to understand interactions between multiple conditions to address population needs and inform health system responses. This multicentre prospective study in Malawi aimed to characterise the aetiologies, outcomes and biomarker accuracy for breathless patients. Methods Adults (aged ≥18 years) admitted to medical wards were consecutively recruited within 24 hours of hospital presentation and followed up for 1 year. Participants with breathlessness (defined as a composite of patient-reported shortness of breath; tachypnoea (respiratory rate ≥25/min); hypoxaemia (SpO2 <94%) or treatment with oxygen) were systematically screened against internationally accepted diagnostic criteria. We estimated disease prevalence, survival, health-related quality of life and functional status. We also evaluated diagnostic accuracy of natriuretic peptides for heart failure, and procalcitonin (PCT) and C reactive peptide (CRP) for pneumonia. Results Of 751 participants, 44% (n=334) had breathlessness, and 316 underwent enhanced diagnostic screening. One-year mortality was higher in breathless patients (51% (157/307)) than those without (26% (100/385)); adjusted HR 1.8 (95% CI 1.4 to 2.3). We identified high prevalence and mortality of heart failure (35% (112/316) prevalence; 69% (75/109) 1-year mortality), anaemia (40% (126/316); 57% (70/122)), pneumonia (41% (131/316); 53% (68/129)) and tuberculosis (29% (91/316); 47% (41/87)). Most participants (63% (199/316)) had multiple conditions. Diagnostic accuracy (area under the curve) for heart failure was 0.89 (brain natriuretic peptide) and 0.88 (N-terminal pro-B-type natriuretic peptide); for pneumonia, CRP was 0.77 and PCT was 0.69. Discussion Breathlessness-related hospital admissions in Malawi are common, multifactorial and associated with poor survival. This study demonstrates that co-existing conditions are common, highlighting the limitation of single-disease-focused health system responses. Integrated care pathways with context-sensitive diagnostic and treatment approaches are urgently needed to improve survival. Data are available on reasonable request. An anonymised study dataset can be shared within Malawi in line with local data sharing policies. Requests for data sharing outside Malawi can be presented to the MultiLink management committee via our programme manager, Amy Smith (Amy.Smith{at}lstmed.ac.uk).
期刊介绍:
Thorax stands as one of the premier respiratory medicine journals globally, featuring clinical and experimental research articles spanning respiratory medicine, pediatrics, immunology, pharmacology, pathology, and surgery. The journal's mission is to publish noteworthy advancements in scientific understanding that are poised to influence clinical practice significantly. This encompasses articles delving into basic and translational mechanisms applicable to clinical material, covering areas such as cell and molecular biology, genetics, epidemiology, and immunology.